What Are Peptides Used For? Research Areas Explained

TL;DR

What are peptides used for? In published research, peptides are short chains of amino acids studied mainly in four areas: metabolic and obesity, growth hormone and body composition, tissue repair, and specific approved indications.

- A small number are FDA-approved drugs (semaglutide, tirzepatide, tesamorelin as Egrifta, bremelanotide as Vyleesi). Many others are investigational or research-only, and that status changes how much the evidence can be trusted. - Retatrutide reached up to about 24.2 percent mean weight change at 48 weeks (Jastreboff et al., 2023). - Tirzepatide reached up to about 22.5 percent (Jastreboff et al., 2022). - Semaglutide produced a mean of roughly -14.9 percent, or about 15 percent (Wilding et al., 2021). - Tesamorelin lowered visceral adipose tissue by about 15 percent (Falutz et al., 2007). - Tissue-repair peptides like BPC-157 and TB-500 rest mostly on animal data, with very limited human evidence (Sikiric et al., 2020).

What are peptides used for in research?

Peptides are short chains of amino acids studied as signaling molecules across metabolic, hormonal, tissue-repair, and reproductive research, with a small number now approved as prescription drugs.

A peptide is a short string of amino acids, the same building blocks that make proteins, only smaller. Because many hormones and signals in the body are themselves peptides, researchers design peptide compounds to copy or block those signals. For the basics of structure and how they differ from proteins, see [/what-are-peptides](/what-are-peptides).

The clearest way to answer "what are peptides used for" is by research area, because the same peptide can appear in more than one context. It also helps to sort every compound into one of three buckets:

- **FDA-approved:** cleared by regulators for a named medical indication. - **Investigational:** being tested in registered human clinical trials, not yet approved. - **Research-only:** studied in cells or animals, with little or no human trial data.

This page describes what published studies report. It does not tell you what to take. Any personal decision belongs with a qualified clinician.

What are peptides used for in obesity and metabolic research?

In metabolic research, incretin-based peptides such as semaglutide, tirzepatide, and retatrutide are studied for their effects on body weight and blood sugar regulation.

These compounds copy gut hormones (GLP-1, and in some cases GIP and glucagon) that influence appetite and insulin. The trial record is large and recent:

- **Semaglutide** is a GLP-1 receptor agonist. In the STEP 1 trial, participants lost about 15 percent of body weight on average, reported as a mean of roughly -14.9 percent, or -15.3 kg versus -2.6 kg on placebo at week 68 (Wilding et al., 2021). It is FDA-approved. - **Tirzepatide** targets both GIP and GLP-1 receptors. In SURMOUNT-1, mean weight reduction reached up to about 22.5 percent at the 15 mg dose (Jastreboff et al., 2022). A head-to-head trial, SURPASS-2, compared it against semaglutide in type 2 diabetes (Frias et al., 2021). It is FDA-approved. - **Retatrutide** acts on three receptors (GIP, GLP-1, and glucagon). In its phase 2 trial, mean weight change reached up to about 24.2 percent at 48 weeks with the 12 mg dose (Jastreboff et al., 2023). It is investigational. - **Cagrilintide** (an amylin analog) and **survodutide** (a GLP-1 and glucagon agonist) have early clinical-trial data (Lau et al., 2021; le Roux et al., 2024). Both are investigational. - **MOTS-c**, a mitochondrial-derived peptide, is studied for AMPK activation and metabolic signaling in preclinical models (Lee et al., 2015). It is research-only.

Research also documents what happens after these studies end. In SURMOUNT-4, participants who withdrew from tirzepatide and switched to placebo regained weight, while those who continued treatment maintained their loss (Aronne et al., 2024). A similar pattern appears after stopping semaglutide, where participants regained about two-thirds of prior weight loss one year after withdrawal (Wilding et al., 2022). Trial trajectories also show that weight loss tends to slow and reach a plateau over time, a pattern linked in part to adaptive thermogenesis, the body's drop in energy use during weight loss (Rosenbaum and Leibel, 2010).

### Research-reported metabolic outcomes

The ranges below reflect what published studies and commonly studied research protocols report. This is educational, not a prescription or a personal recommendation.

These figures are outcomes from named trials, not dosing instructions. The doses used, and whether any peptide fits a given person, are questions for a licensed clinician.

What are peptides used for in growth hormone and body-composition research?

A group of peptides is studied for its effect on growth hormone release and body composition, including tesamorelin, CJC-1295, ipamorelin, and the oral secretagogue MK-677.

Rather than adding growth hormone directly, most of these compounds prompt the body to release more of its own.

- **Tesamorelin** is a GHRH analog. It reduced visceral adipose tissue by about 15.2 percent versus a 5.0 percent rise on placebo (Falutz et al., 2007) and is FDA-approved as Egrifta, indicated for HIV-associated lipodystrophy. - **CJC-1295** is a longer-acting GHRH analog reported to raise and sustain growth hormone and IGF-1 levels after a single dose (Teichman et al., 2006). It is investigational and used in research settings. - **Ipamorelin** is described as a selective growth hormone secretagogue that raises growth hormone with minimal effect on cortisol and prolactin (Raun et al., 1998). It is research-only. - **MK-677 (ibutamoren)** is an orally active growth hormone secretagogue often grouped with peptides, though it is technically a small molecule, not a peptide. In one 12-month study it raised fasting glucose and lowered insulin sensitivity at 25 mg per day (Nass et al., 2008), a tradeoff worth noting. It is investigational.

What are peptides used for in tissue-repair and skin research?

Peptides like BPC-157, TB-500, and GHK-Cu are studied mostly in animal and cell models for tissue-repair and regenerative signaling, and human evidence remains limited.

- **BPC-157** is a synthetic pentadecapeptide studied heavily in animal models of gut and soft-tissue healing, with mechanisms that include VEGFR2 and the nitric-oxide pathway. Human data are very limited, and the animal work dominates the record (Sikiric et al., 2020). It is research-only and not approved. - **TB-500** is sold as a fragment or analog related to thymosin beta-4. Thymosin beta-4 itself accelerated wound reepithelialization in animal work (Malinda et al., 1999), but human data on TB-500 specifically are limited, so any human relevance is largely unproven. It is research-only. - **GHK-Cu** is a copper tripeptide reviewed for skin and regenerative signaling, including stimulation of collagen and elastin synthesis and modulation of gene expression (Pickart and Margolina, 2018). It is research-only for most claims.

Because the strongest tissue-repair evidence comes from animals, treat human extrapolation with caution. What works in a rodent model does not always transfer to people.

What are peptides used for in sexual-health and reproductive research?

Bremelanotide (PT-141) is FDA-approved for a specific sexual-health indication, while kisspeptin is studied for its role in reproductive-axis signaling.

- **Bremelanotide (PT-141)** is a melanocortin receptor agonist, FDA-approved as Vyleesi and indicated for hypoactive sexual desire disorder in premenopausal women. In the RECONNECT phase 3 program of about 1,247 women, a 1.75 mg subcutaneous as-needed dose met the co-primary desire and distress endpoints, and nausea was the most common adverse event (Kingsberg et al., 2019). - **Kisspeptin** is a peptide studied for its role in signaling the reproductive hormone axis, shown to raise LH, FSH, and testosterone in healthy men (Dhillo et al., 2005). It is research-focused.

Which peptides are FDA-approved, investigational, or research-only?

Only a handful of peptides are FDA-approved drugs; most peptides discussed online are investigational or research-only, and that status tells you how much human evidence exists behind them.

Reading this table is the fastest way to gauge evidence. An FDA-approved peptide has cleared human trials for a named indication. An investigational one has human data but no approval. A research-only compound may have promising animal signals and little more.